ASTRO 2024: SABR for primary kidney cancer – Is it ready for ‘primetime’?
In this presentation at the 2024 American Society for Radiation [...]
Clinical impact of the CARMENA trial on cytoreductive nephrectomy in the USA
A recent study looked at whether the use of cytoreductive [...]
Biopsy of small renal masses leads to fewer radical nephrectomies
This study looks at how how the biopsy of small [...]
Factors affecting outcomes after nephrectomy for metastatic kidney cancer
Nephrectomy is surgery to remove all or part of a [...]
Kidney function 5 years after SABR for primary kidney cancer
Stereotactic ablative body radiotherapy (SABR) uses high doses of radiation [...]
SABR for older patients with inoperable kidney cancer
The incidence of renal cell carcinoma (RCC) has increased worldwide [...]
Leicester NHS Trust receives funding for robotic surgery theatre
Robotic surgery will be used in more procedures in Leicester [...]
Partial nephrectomy versus ablation for early stage kidney cancer in the elderly
A recent study compared the success of robot-assisted partial nephrectomy [...]
Stereotactic ablative radiotherapy for primary kidney cancer
Stereotactic ablative radiotherapy (SABR) for treating the primary kidney cancer [...]
Radiofrequency ablation for small renal masses
The standard treatment for small renal masses is to remove [...]
